Weight loss medications have been linked to a series of surprising health issues, according to new research.
The multinational study, presented at the European Academy of Dermatology and Venereology (EADV) Congress, examined patients using the GLP-1 group of medications, which include drugs such as Ozempic, Wegovy and Mounjaro.